Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Jennifer L. Geurts MS, CGC

Jennifer L. Geurts MS, CGC profile photo picture

Director, Assistant Professor

Institution: Medical College of Wisconsin
Department: Institute for Health and Equity
Division: Administration
Program: Administration

Director of the Institute for Health & Equity

Publications (26)

  • Germline evaluation of patients undergoing tumor genomic profiling: An academic cancer center's experience with implementing a germline review protocol. (Stachowiak S, Jacquart A, Zimmermann MT, George B, Dong H, Geurts JL) J Genet Couns 2021 Jun;30(3):900-910 PMID: 33754402 SCOPUS ID: 2-s2.0-85102814588 03/24/2021    
  • Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level. (Zimmermann MT, Mathison AJ, Stodola T, Evans DB, Abrudan JL, Demos W, Tschannen M, Aldakkak M, Geurts J, Lomberk G, Tsai S, Urrutia R) Front Oncol 2021;11:606820 PMID: 33747920 PMCID: PMC7973372 SCOPUS ID: 2-s2.0-85102941394 03/23/2021       4 Citations
  • Does Supply Equal Demand? The Workforce of Direct Patient Care Genetic Counselors in Wisconsin. (Dawson C, Syverson E, Chelius TH, Linn S, Reiser C, Stuewe K, Zoran S, Geurts JL) WMJ 2020 Sep;119(3):158-164 PMID: 33091282 SCOPUS ID: 2-s2.0-85094155867 10/23/2020       3 Citations
  • Cost-effectiveness analysis of universal germline testing for patients with pancreatic cancer. (Krepline AN, Geurts JL, George B, Kamgar M, Madhavan S, Erickson BA, Hall WA, Griffin MO, Evans DB, Tsai S, Kim RY) Surgery 2021 Mar;169(3):629-635 PMID: 32826069 SCOPUS ID: 2-s2.0-85089521842 08/23/2020       3 Citations
  • Inherited syndromes involving pancreatic neuroendocrine tumors. (Geurts JL) J Gastrointest Oncol 2020 Jun;11(3):559-566 PMID: 32655935 PMCID: PMC7340802 SCOPUS ID: 2-s2.0-85090272085 07/14/2020       17 Citations
  • Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB (Oxford) 2020 Dec;22(12):1745-1752 PMID: 32354656 SCOPUS ID: 2-s2.0-85083782398 05/02/2020       2 Citations
  • Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes. (Landrith T, Li B, Cass AA, Conner BR, LaDuca H, McKenna DB, Maxwell KN, Domchek S, Morman NA, Heinlen C, Wham D, Koptiuch C, Vagher J, Rivera R, Bunnell A, Patel G, Geurts JL, Depas MM, Gaonkar S, Pirzadeh-Miller S, Krukenberg R, Seidel M, Pilarski R, Farmer M, Pyrtel K, Milliron K, Lee J, Hoodfar E, Nathan D, Ganzak AC, Wu S, Vuong H, Xu D, Arulmoli A, Parra M, Hoang L, Molparia B, Fennessy M, Fox S, Charpentier S, Burdette J, Pesaran T, Profato J, Smith B, Haynes G, Dalton E, Crandall JR, Baxter R, Lu HM, Tippin-Davis B, Elliott A, Chao E, Karam R) NPJ Precis Oncol 2020;4:4 PMID: 32133419 PMCID: PMC7039900 SCOPUS ID: 2-s2.0-85090004767 03/07/2020       43 Citations
  • HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes. (Brock P, Geurts JL, Van Galen P, Blouch E, Welch J, Kunz A, Desrosiers L, Gauerke J, Hyde S) Endocr Relat Cancer 2020 Aug;27(8):T65-T75 PMID: 32106089 SCOPUS ID: 2-s2.0-85087465531 02/28/2020       1 Citation
  • Screening guidelines and recommendations for patients at high risk of developing endocrine cancers. (Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN) J Surg Oncol 2020 May;121(6):975-983 PMID: 32090344 SCOPUS ID: 2-s2.0-85083530980 02/25/2020       6 Citations
  • OVARIAN GRANULOSA CELL TUMOR IN A PATIENT WITH A PATHOGENIC VARIANT IN THE CDC73 GENE (HYPERPARATHYROIDISM-JAW TUMOR SYNDROME). (Sirbiladze RL, Uyar D, Geurts JL, Shaker JL) AACE Clin Case Rep 2019;5(3):e222-e225 PMID: 31967039 PMCID: PMC6876943 SCOPUS ID: 2-s2.0-85105277552 01/23/2020       4 Citations
  • Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? (Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2020 Feb;24(2):235-242 PMID: 31745905 SCOPUS ID: 2-s2.0-85076028351 11/21/2019       7 Citations
  • Tubulopapillary adrenocortical adenoma in a patient with familial adenomatous polyposis: a morphologic, ultrastructural, and molecular study. (Huang H, Chang J, Rosati S, Geurts J, Mackinnon AC) Hum Pathol 2019 May;87:51-56 PMID: 30172912 SCOPUS ID: 2-s2.0-85063968209 09/03/2018    
  • Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer. (Uyar D, Neary J, Monroe A, Nugent M, Simpson P, Geurts JL) Gynecol Oncol 2018 Jun;149(3):565-569 PMID: 29653687 SCOPUS ID: 2-s2.0-85045079578 04/15/2018       23 Citations
  • Development of a high risk pancreatic screening clinic using 3.0 T MRI. (Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P, Tolat P, Hohenwalter M, Dua K, Khan AH, Evans DB, Geurts J, Tsai S) Fam Cancer 2018 Jan;17(1):101-111 PMID: 29101607 SCOPUS ID: 2-s2.0-85032808589 11/05/2017       18 Citations
  • Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. (Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL) Am J Surg 2016 Oct;212(4):660-669 PMID: 27649974 SCOPUS ID: 2-s2.0-84991709374 09/22/2016       154 Citations
  • Genetic evaluation of the patient with medullary thyroid cancer (Geurts JL) Medullary Thyroid Cancer 20 July 2016:65-75 SCOPUS ID: 2-s2.0-85026530687 07/20/2016    
  • Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency. (Sachs Z, Been RA, DeCoursin KJ, Nguyen HT, Mohd Hassan NA, Noble-Orcutt KE, Eckfeldt CE, Pomeroy EJ, Diaz-Flores E, Geurts JL, Diers MD, Hasz DE, Morgan KJ, MacMillan ML, Shannon KM, Largaespada DA, Wiesner SM) Haematologica 2016 Oct;101(10):1190-1199 PMID: 27418650 PMCID: PMC5046648 SCOPUS ID: 2-s2.0-84989333097 07/16/2016       15 Citations
  • Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines. (Marcus RK, Geurts JL, Grzybowski JA, Turaga KK, Clark Gamblin T, Strong KA, Johnston FM) Fam Cancer 2015 Dec;14(4):641-9 PMID: 26108897 SCOPUS ID: 2-s2.0-84946479011 06/26/2015       11 Citations
  • In the absence of evidentiary harm, existing societal norms regarding parental authority should prevail. (Strong KA, Derse AR, Dimmock DP, Zusevics KL, Jeruzal J, Worthey E, Bick D, Scharer G, La Pean Kirschner A, Spellecy R, Farrell MH, Geurts J, Veith R, May T) Am J Bioeth 2014;14(3):24-6 PMID: 24592835 SCOPUS ID: 2-s2.0-84897678644 03/07/2014       5 Citations
  • Genomics in clinical practice: lessons from the front lines. (Jacob HJ, Abrams K, Bick DP, Brodie K, Dimmock DP, Farrell M, Geurts J, Harris J, Helbling D, Joers BJ, Kliegman R, Kowalski G, Lazar J, Margolis DA, North P, Northup J, Roquemore-Goins A, Scharer G, Shimoyama M, Strong K, Taylor B, Tsaih SW, Tschannen MR, Veith RL, Wendt-Andrae J, Wilk B, Worthey EA) Sci Transl Med 2013 Jul 17;5(194):194cm5 PMID: 23863829 SCOPUS ID: 2-s2.0-84880547053 07/19/2013       80 Citations
  • Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. (Wiesner SM, Geurts JL, Diers MD, Bergerson RJ, Hasz DE, Morgan KJ, Largaespada DA) Am J Hematol 2011 Jul;86(7):579-85 PMID: 21681782 PMCID: PMC3506005 SCOPUS ID: 2-s2.0-79959347114 06/18/2011       5 Citations
  • Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. (Kim A, Morgan K, Hasz DE, Wiesner SM, Lauchle JO, Geurts JL, Diers MD, Le DT, Kogan SC, Parada LF, Shannon K, Largaespada DA) Blood 2007 Feb 15;109(4):1687-91 PMID: 17090653 PMCID: PMC1794059 SCOPUS ID: 2-s2.0-33846902274 11/09/2006       22 Citations
  • Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. (Geurts AM, Collier LS, Geurts JL, Oseth LL, Bell ML, Mu D, Lucito R, Godbout SA, Green LE, Lowe SW, Hirsch BA, Leinwand LA, Largaespada DA) PLoS Genet 2006 Sep 29;2(9):e156 PMID: 17009875 PMCID: PMC1584263 SCOPUS ID: 2-s2.0-33749416026 10/03/2006       86 Citations
  • Erratum to "Sleeping Beauty-Mediated Transposition and Long-Term Expression in Vivo: Use of the LoxP/Cre Recombinase System to Distinguish Transposition-Specific Expression" (DOI:10.1016/j.ymthe.2005.10.015) (Score PR, Belur LR, Frandsen JL, Geurts JL, Yamaguchi T, Somia NV, Hackett PB, Largaespada DA, McIvor RS) Molecular Therapy July 2006;14(1):149 SCOPUS ID: 2-s2.0-33745239722 07/01/2006    
  • RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. (Wilber A, Frandsen JL, Geurts JL, Largaespada DA, Hackett PB, McIvor RS) Mol Ther 2006 Mar;13(3):625-30 PMID: 16368272 SCOPUS ID: 2-s2.0-32944463921 12/22/2005       106 Citations
  • Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression. (Score PR, Belur LR, Frandsen JL, Geurts JL, Yamaguchi T, Somia NV, Hackett PB, Largaespada DA, McIvor RS) Mol Ther 2006 Mar;13(3):617-24 PMID: 16356773 SCOPUS ID: 2-s2.0-32944458256 12/17/2005       27 Citations
    • Last update: 07/27/2023